Skip to main content

$0.125 (0.00%)

High

$0.13

Low

$0.12

Trades

20

Turnover

$48,049

Volume

400,697
30 June 2023 at 3:57pm
Register to track CYP and receive email alerts.

[ARTICLE] Why this CEO brainstorms while sitting on a surfboard

A news article has been posted about Cynata Therapeutics on the AFR. The article was published around , on 11 July 2022 at 9:14am.

Cynata Therapeutics boss Dr Ross Macdonald likes to think outside the box when solving problems. Where better to do so than off the coast?

Read Article

CYP was $0.37 at the close of trade on 08 July 2022

Recent Articles about ASX:CYP
21-Jun CYP:ASX Announcement - Cynata Establishes New Scientific ...

company-announcements.afr.com

10-Jun Notification of issue, conversion or payment up of unquoted equity ...

company-announcements.afr.com

7-Jun CYP:ASX Announcement - Australian Federal Government ...

company-announcements.afr.com

4-Jun Appendix 3B - Proposed issue of securities

company-announcements.afr.com

22-May CYP:ASX Announcement - March 2025 Quarterly Activity Report and ...

company-announcements.afr.com

17-May CYP:ASX Announcement - CYP-001s FDA Approval Pathway Not ...

company-announcements.afr.com

26-Apr CYP:ASX Announcement - Promising Preclinical Heart Disease ...

company-announcements.afr.com

26-Apr Cynata to Present at Euroz Hartleys Healthcare Forum

company-announcements.afr.com

20-Mar CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial

company-announcements.afr.com

12-Mar CYP:ASX Announcement - Application for quotation of securities ...

company-announcements.afr.com

Tracked

Find all articles about Cynata Therapeutics, including others on the AFR, on the media page.

You must login or register to post a comment.

You must be logged in to post a reply.

Register to track CYP and receive email alerts.